These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 10630643)

  • 21. Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis.
    Belton OA; Duffy A; Toomey S; Fitzgerald DJ
    Circulation; 2003 Dec; 108(24):3017-23. PubMed ID: 14638539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2.
    Dannenberg AJ; Zakim D
    Semin Oncol; 1999 Oct; 26(5):499-504. PubMed ID: 10528897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COX selectivity and animal models for colon cancer.
    Oshima M; Taketo MM
    Curr Pharm Des; 2002; 8(12):1021-34. PubMed ID: 11945149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
    Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice.
    Chulada PC; Thompson MB; Mahler JF; Doyle CM; Gaul BW; Lee C; Tiano HF; Morham SG; Smithies O; Langenbach R
    Cancer Res; 2000 Sep; 60(17):4705-8. PubMed ID: 10987272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical expression of cyclooxygenase isoenzymes and downstream enzymes in human lung tumors.
    Ermert L; Dierkes C; Ermert M
    Clin Cancer Res; 2003 May; 9(5):1604-10. PubMed ID: 12738712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancers.
    Koki AT; Khan NK; Woerner BM; Seibert K; Harmon JL; Dannenberg AJ; Soslow RA; Masferrer JL
    Prostaglandins Leukot Essent Fatty Acids; 2002 Jan; 66(1):13-8. PubMed ID: 12051953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostaglandin J2 and 15-deoxy-delta12,14-prostaglandin J2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells.
    Chinery R; Coffey RJ; Graves-Deal R; Kirkland SC; Sanchez SC; Zackert WE; Oates JA; Morrow JD
    Cancer Res; 1999 Jun; 59(11):2739-46. PubMed ID: 10364000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review.
    Pruthi RS; Derksen E; Gaston K
    J Urol; 2003 Jun; 169(6):2352-9. PubMed ID: 12771797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of colorectal cancer through the use of COX-2 selective inhibitors.
    Peek RM
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S50-6. PubMed ID: 15309515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke.
    Ye YN; Wu WK; Shin VY; Bruce IC; Wong BC; Cho CH
    Carcinogenesis; 2005 Apr; 26(4):827-34. PubMed ID: 15637091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
    Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
    Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor).
    Poon R; Smits R; Li C; Jagmohan-Changur S; Kong M; Cheon S; Yu C; Fodde R; Alman BA
    Oncogene; 2001 Jan; 20(4):451-60. PubMed ID: 11313976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biological functions of cyclooxygenase 2: control of its expression and activity].
    Jacquemin C
    J Soc Biol; 2000; 194(3-4):189-93. PubMed ID: 11324321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors.
    Katori M; Majima M
    Inflamm Res; 2000 Aug; 49(8):367-92. PubMed ID: 11028754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic evidence for distinct roles of COX-1 and COX-2 in the immediate and delayed phases of prostaglandin synthesis in mast cells.
    Reddy ST; Tiano HF; Langenbach R; Morham SG; Herschman HR
    Biochem Biophys Res Commun; 1999 Nov; 265(1):205-10. PubMed ID: 10548515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.
    Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF
    Cancer Res; 2001 Feb; 61(4):1733-40. PubMed ID: 11245490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.
    Sheng H; Shao J; Kirkland SC; Isakson P; Coffey RJ; Morrow J; Beauchamp RD; DuBois RN
    J Clin Invest; 1997 May; 99(9):2254-9. PubMed ID: 9151799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II).
    Taketo MM
    J Natl Cancer Inst; 1998 Nov; 90(21):1609-20. PubMed ID: 9811310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.